Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Cellular Biochemistry|September 6, 2007
Cloning and characterisation of Ifi206: a new murine HIN-200 family memberLouise E Ludlow, Linda L Hii, Janine Thorpe, et al.
Cell Death & Disease|January 6, 2026
Dual Bcl-2/Bcl-xl inhibition via AZD0466 combines with immune checkpoint blockade to enhance anti-tumour activityDane M Newman, Courtney L Andersen, Leonie A Cluse, et al.
Blood|December 9, 2008
Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitorsKate F Whitecross, Amber E Alsop, Leonie A Cluse, et al.
Blood|April 23, 2009
The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacyLeigh Ellis, Michael Bots, Ralph K Lindemann, et al.
Cell Reports|February 25, 2016
Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma CellsLiz J Valente, Brandon J Aubrey, Marco J Herold, et al.
Molecular Cancer Therapeutics|July 14, 2016
BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family MembersSimon J Hogg, Andrea Newbold, Stephin J Vervoort, et al.
The Journal of Biological Chemistry|December 3, 2004
A central role for Bid in granzyme B-induced apoptosisNigel J Waterhouse, Karin A Sedelies, Kylie A Browne, et al.
Cancer Discovery|January 13, 2021
Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD-Driven Acute Myeloid LeukemiaStefan Bjelosevic, Emily Gruber, Andrea Newbold, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2023
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphomaDanielle H Oh, Xiao Ma, Simon J Hogg, et al.
Blood|February 14, 2013
Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomasJake Shortt, Benjamin P Martin, Andrea Newbold, et al.
Pageof 3